CRISPR Therapeutics Appoints Sivakesava Sakhamuri as Chief Technical Officer
CRISPR Therapeutics (CRSP) has announced the immediate appointment of Sivakesava Sakhamuri as its new Chief Technical Officer. Sakhamuri transitions to the role from Orna Therapeutics, where he previously served as CTO. With three decades of experience in technical operations and manufacturing, Sakhamuri specializes in biologics, vaccines, RNA therapeutics, and lipid nanoparticle delivery systems. His leadership is expected to bolster the company's technical infrastructure and manufacturing capabilities for its gene-editing pipeline.
Tickers: $CRSP